Xavier Dagenais-Lussier

Mr. Xavier Dagenais-Lussier

INRS-Armand-Frappier Santé Biotechnologie
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
XDXavier Dagenais-Lussier
Xavier Dagenais-Lussier
MAMouna Aounallah
Mouna Aounallah
VMVikram Mehraj
Vikram Mehraj
MEMohamed El-Far
Mohamed El-Far
CTCecile Tremblay
Cecile Tremblay
JGJulien Van Grevenynghe
Julien Van Grevenynghe
Early HIV-1 infection is characterized by enhanced tryptophan catabolism, which contributes to immune suppression and disease progression. However, the mechanism by which kynurenine, a tryptophan-related metabolite, induces immune suppression remains poorly understood. Herein, we show that the increased production of kynurenine correlates with defective interleukin-2 (IL-2) signaling in memory CD4 T cells from HIV-infected subjects. Defective IL-2 signaling in these subjects, which drives reduced protection from Fas-mediated apoptosis, was also associated with memory CD4 T-cell loss. Treatment of memory CD4 T cells with the concentration of kynurenine found in plasma inhibited IL-2 signaling through the production of reactive oxygen species. We further show that IL-2 signaling in memory CD4 T cells is improved by the antioxidant N -acetylcysteine. Early initiation of antiretroviral therapy restored the IL-2 response in memory CD4 T cells by reducing reactive oxygen species and kynurenine production. The study findings provide a kynurenine-dependent mechanism through IL-2 signaling for reduced CD4 T-cell survival, which can be reversed by early treatment initiation in HIV-1 infection. IMPORTANCE The persistence of functional memory CD4 T cells represents the basis for long-lasting immune protection in individuals after exposure to HIV-1. Unfortunately, primary HIV-1 infection results in the massive loss of these cells within weeks of infection, which is mainly driven by inflammation and massive infection by the virus. These new findings show that the enhanced production of kynurenine, a metabolite related to tryptophan catabolism, also impairs memory CD4 T-cell survival and interferes with IL-2 signaling early during HIV-1 infection.

1 December 2015 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
XDXavier Dagenais-Lussier
Xavier Dagenais-Lussier
AMAounallah Mouna
Aounallah Mouna
JRJean-Pierre Routy
Jean-Pierre Routy
CTCecile Tremblay
Cecile Tremblay
RSRafick-Pierre Sekaly
Rafick-Pierre Sekaly
JGJulien Van Grevenynghe
Julien Van Grevenynghe

1 April 2016 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
MAMouna Aounallah
Mouna Aounallah
XDXavier Dagenais-Lussier
Xavier Dagenais-Lussier
MEMohamed El-Far
Mohamed El-Far
VMVikram Mehraj
Vikram Mehraj
MJMohammad-Ali Jenabian
Mohammad-Ali Jenabian
JGJulien Van Grevenynghe
Julien Van Grevenynghe

30 December 2017 in Viruses
Verified
Journal Article
Open access
PDF file
XDXavier Dagenais-Lussier
Xavier Dagenais-Lussier
HLHamza Loucif
Hamza Loucif
AMArmstrong MuRIRA
Armstrong MuRIRA
XLXavier Laulhe
Xavier Laulhe
SSSimona Stäger
Simona Stäger
JGJulien Van Grevenynghe
Julien Van Grevenynghe
Type I interferons (IFN-I) are one of the primary immune defenses against viruses. Similar to all other molecular mechanisms that are central to eliciting protective immune responses, IFN-I expression is subject to homeostatic controls that regulate cytokine levels upon clearing the infection. However, in the case of established persistent viral infection, sustained elevation of IFN-I expression bears deleterious effects to the host and is today considered as the major driver of inflammation and immunosuppression. In fact, numerous emerging studies place sustained IFN-I expression as a common nexus in the pathogenesis of multiple chronic diseases including persistent infections with the human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus (SIV), as well as the rodent-borne lymphocytic choriomeningitis virus clone 13 (LCMV clone 13). In this review, we highlight recent studies illustrating the molecular dysregulation and resultant cellular dysfunction in both innate and adaptive immune responses driven by sustained IFN-I expression. Here, we place particular emphasis on the efficacy of IFN-I receptor (IFNR) blockade towards improving immune responses against viral infections given the emerging therapeutic approach of blocking IFNR using neutralizing antibodies (Abs) in chronically infected patients.

1 June 2021 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
XDXavier Dagenais-Lussier
Xavier Dagenais-Lussier
HLHamza Loucif
Hamza Loucif
CBCherifa Beji
Cherifa Beji
RTRoman Telittchenko
Roman Telittchenko
JRJean-Pierre Routy
Jean-Pierre Routy
JGJulien Van Grevenynghe
Julien Van Grevenynghe

28 October 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
XDXavier Dagenais-Lussier
Xavier Dagenais-Lussier
HLHamza Loucif
Hamza Loucif
HCHugo Cadorel
Hugo Cadorel
JBJuliette Blumberger
Juliette Blumberger
SIStéphane Isnard
Stéphane Isnard
FGfor the Montreal Primary Infection Study Group
for the Montreal Primary Infection Study Group
The loss of Memory CD4 T-cells (Mem) is a major hallmark of HIV-1 immuno-pathogenesis and occurs early during the first months of primary infection. A lot of effort has been put into understanding the molecular mechanisms behind this loss, yet they still have not been fully identified. In this study, we unveil the unreported role of USP18 in the deleterious effects of sustained type I IFN signaling on Mem, including HIV-1-specific CD4 T-cells. We find that interfering with IFN-I signaling pathway in infected patients, notably by targeting the interferon-stimulated gene USP18, resulted in reduced PTEN expression similar to those observed in uninfected control donors. We show that AKT activation in response to cytokine treatment, T-cell receptor (TcR) triggering, as well as HIV-1 Gag stimulation was significantly improved in infected patients when PTEN or USP18 were inhibited. Finally, our data demonstrate that higher USP18 in Mem from infected patients prevent proper cell survival and long-lasting maintenance in an AKT-dependent manner. Altogether, we establish a direct role for type I IFN/USP18 signaling in the maintenance of total and virus-specific Mem and provide a new mechanism for the reduced survival of these populations during primary HIV-1 infection. In this study, we expend our knowledge of how type I interferons (IFN-I) leads to memory CD4 T-cell defective survival by unveiling the molecular mechanism behind such impairments, placing USP18 at its center. Our data further deciphers the specific USP18-related mechanism that is responsible for such impairments by implicating AKT inhibition in a PTEN-dependent manner. Our findings also point to a potential use of neutralizing anti-interferon α/β receptor antibodies to rescue the defective memory CD4 T-cell survival during HIV-1 infection, even in HIV-1 specific CD4 T-cell. To conclude, our findings provide the characterization of the molecular pathway leading to disturbances caused by sustained IFN-I signaling which occurs early during primary HIV-1 infection, complementing current knowledge which placed sustained IFN-I signaling as detrimental to the host during this infection.